DC Circ. Won't Revisit Revival Of Pharma Terror-Funding Case
By Katie Buehler · February 3, 2023, 6:50 PM EST
The full D.C. Circuit will not review a panel's revival of a lawsuit accusing AstraZeneca Pharmaceuticals LP, Pfizer Inc. and several other pharmaceutical companies of helping finance terror attacks that injured...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login